An in vitro diagnostic device designed for rapid on-site detection of viruses. The device leverages digital microfluidic technology to provide efficient and cost-effective testing solutions. It enables multiple tests to be performed on a single instrument platform.
Manufactured by
China
Digifluidic Biotech, established in 2018, specializes in automated nucleic acid analysis equipment and microfluidic chips. Core technology developed over 10+ years at the University of Macau State Key Laboratory. The company focuses on molecular diagnostics using digital microfluidic technology, producing rapid gene detection systems for medical diagnostics, food safety, and quarantine inspection applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hochuen Medical USA Corp.
United States · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 2 relevant products
Beijing Poly Microchip Techonology CO,.LTD
China · 2 relevant products
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
Xiamen Micalrun Technology Co.,Ltd
China · 1 relevant product
Suzhou welgwiyan Precision Technology Co.,Ltd
China · 1 relevant product
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 1 relevant product
Rapid Viral Detection Systems
United States · 3 relevant products
Xenta Biomedical Science Co.,Ltd
China · 1 relevant product
Fujirebio Europe
Belgium · 1 relevant product
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 63 closest product alternatives
Hochuen Medical USA Corp. · United States
Microfluidic device for point-of-care testing and in vitro diagnostics applications. Enables precise fluid handling and sample analysis in compact formats, supporting rapid diagnostic workflows. FDA-registered and ISO-certified platform suitable for IVD manufacturing and clinical laboratory use.
ZIODIA Co., Ltd. · South Korea
Compact platform for performing in vitro diagnostic testing utilizing advanced microfluidic technology. Delivers laboratory-quality results while reducing time to diagnosis and associated testing costs.
Beijing Poly Microchip Techonology CO,.LTD · China
Integrated microfluidic platforms for molecular-level disease detection and pathogen identification. Combines sample preparation, amplification, and detection in a single miniaturized device for clinical diagnostics.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic solution for rapid COVID-19 detection. Provides point-of-care testing capabilities for viral identification.
Xiamen Micalrun Technology Co.,Ltd · China
Infectious disease detection kits utilizing microfluidic chip, fluorescence quantitative PCR, and isothermal amplification technologies for rapid pathogen identification and diagnosis. Designed for epidemic screening, disease diagnosis, and clinical monitoring across multiple infectious disease applications.
Suzhou welgwiyan Precision Technology Co.,Ltd · China
Integrated microfluidic-based systems for in vitro diagnostics supporting molecular detection and biomarker analysis. These systems provide automated processing and detection capabilities for clinical laboratory applications.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Testing platform for rapid detection of SARS-CoV-2. Suitable for screening and confirmation in hospitals, clinics, and point-of-care settings.
Rapid Viral Detection Systems · United States
ViralStatDx is a portable point-of-care (POC) diagnostic device for rapid detection of infectious diseases with 99% accuracy and 100% sensitivity. The platform delivers results in minimal time, making it suitable for clinical settings requiring fast viral screening. Featuring highly-sensitive detection technology and 98.85% specificity, it offers a cost-effective alternative to conventional test kits.
Xenta Biomedical Science Co.,Ltd · China
An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.
Fujirebio Europe · Belgium
Advanced microfluidic-based diagnostic assay technology for reduced sample volume and rapid testing. Provides ultra-sensitive detection capabilities for clinical applications.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Comprehensive diagnostic system for detecting various viral pathogens in clinical specimens. Products include multiple viral targets with established immunoassay protocols.
Shenzhen Kerch Technology Co., Ltd. · China
Integrated microfluidic systems for point-of-care diagnostics and laboratory testing applications. Platforms support automated sample processing and rapid result generation for clinical diagnostics.
51 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products